SCHEMBL6152286

SCHEMBL6152286

Cc1ccc(-c2ccc(C3=C4C(=O)N(C)C(c5ccc(-c6ccc(C)cc6)c6ccccc56)=C4C(=O)N3C)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
PTGS2 P35354 1/20 0.41
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
APP P05067 1/20 0.38
CASP3 P42574 1/20 0.38
TTR P02766 1/20 0.38
BRD4 O60885 1/20 0.38
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12394336 0.81 PPARG (0.44) CYP1A2CYP2C19POLBBRD4
SCHEMBL6153208 0.79 RGS4 (0.47) SIRT2ALDH1A1MEN1POLBKMT2A
SCHEMBL9836026 0.78 PTGS2 (0.50) PTGS2ALDH1A1KDM4ECYP2C19HSD17B10
SCHEMBL26332330 0.78 COMT (0.53) COMTALDH1A1KDM4ETSHRMEN1
SCHEMBL12394337 0.77 POLB (0.45) SIRT2SIRT1ALDH1A1KDM4ECYP1A2
SCHEMBL12725183 0.76 PTGS2 (0.49) PTGS2CYP2C19HSD17B10MEN1POLB
SCHEMBL6152442 0.76 POLB (0.47) SIRT2SIRT1ALDH1A1KDM4ECYP1A2
SCHEMBL12394320 0.75 KDM4E (0.42) SIRT2SIRT1ALDH1A1KDM4ECYP1A2
SCHEMBL12394328 0.75 PPARG (0.41) CYP2C19HSD17B10POLBBRD4
SCHEMBL6152713 0.74 MCL1 (0.40) SIRT2SIRT1KDM4ECYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253151-B1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES (JP) 2005-01-12 EP disclosed
US-6805978-B2 COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND TORAY INDUSTRIES, INC. (JP) 2004-10-19 US disclosed
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound TORAY INDUSTRIES, INC. (JP) 2003-05-01 US disclosed
EP-1253151-A1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES, INC. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound PPOX, CPNE4, TP53RK COMT 1296/4885SIRT2 3722/4885SIRT1 3580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.